What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Peter Arner spends much of his time researching Internal medicine, Endocrinology, Adipose tissue, Lipolysis and Adipocyte.
The Internal medicine study combines topics in areas such as Diabetes mellitus and Type 2 diabetes.
His research combines Receptor and Endocrinology.
Peter Arner interconnects Tumor necrosis factor alpha, Hormone and Gene expression in the investigation of issues within Adipose tissue.
His Lipolysis study combines topics from a wide range of disciplines, such as Lipase, Beta, Triglyceride and Adrenergic receptor.
His work in Adipocyte addresses issues such as Isoprenaline, which are connected to fields such as Epinephrine and Propranolol.
His most cited work include:
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. (2948 citations)
- The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. (2704 citations)
- Dynamics of fat cell turnover in humans. (1636 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Endocrinology, Adipose tissue, Lipolysis and Adipocyte.
Much of his study explores Internal medicine relationship to Diabetes mellitus.
In his research on the topic of Endocrinology, Skeletal muscle is strongly related with Microdialysis.
His research integrates issues of Carbohydrate metabolism and Leptin in his study of Adipose tissue.
Peter Arner interconnects Isoprenaline, Hormone, Catecholamine and Glycerol in the investigation of issues within Lipolysis.
His Adipocyte study integrates concerns from other disciplines, such as Agonist, Adipokine, Triglyceride and Adrenergic receptor.
He most often published in these fields:
- Internal medicine (83.30%)
- Endocrinology (82.03%)
- Adipose tissue (62.98%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (83.30%)
- Endocrinology (82.03%)
- Adipose tissue (62.98%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Endocrinology, Adipose tissue, Adipocyte and Insulin resistance.
Internal medicine is closely attributed to Diabetes mellitus in his study.
His Endocrinology study typically links adjacent topics like Gene expression.
In his study, which falls under the umbrella issue of Adipose tissue, Transcription factor and Cellular differentiation is strongly linked to Cell biology.
The Adipocyte study combines topics in areas such as Body mass index, Downregulation and upregulation and Lipoprotein.
His Insulin resistance research is multidisciplinary, relying on both Carbohydrate metabolism and Surgery.
Between 2012 and 2021, his most popular works were:
- A promoter-level mammalian expression atlas (1307 citations)
- Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells (378 citations)
- MicroRNA regulatory networks in human adipose tissue and obesity (250 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Peter Arner mainly focuses on Internal medicine, Endocrinology, Adipose tissue, Insulin resistance and Adipocyte.
Peter Arner combines subjects such as microRNA, Epigenetics and DNA methylation with his study of Internal medicine.
In his research, Promoter and Cell biology is intimately related to Regulation of gene expression, which falls under the overarching field of Endocrinology.
His Adipose tissue research incorporates elements of Obesity and Triglyceride.
His Insulin resistance research includes themes of Carbohydrate metabolism, Gastric bypass surgery, Surgery and Omentectomy.
The concepts of his Adipocyte study are interwoven with issues in Body mass index and Lipoprotein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
